Olivia's Feed
Apr 21, 2015

Top Mylan shareholders seek deal with Teva -sources

April 21 (Reuters) – Some of the top investors at Mylan NV
, including Paulson & Co, are encouraging its board of
directors to consider a takeover proposal from rival Teva
Pharmaceutical Industries Inc, according to people
familiar with the matter.

A handful of these investors have expressed their support in
recent weeks for the creation of the world’s largest generic
drug maker by sales, these people said, declining to be named
because they were not authorized to speak to the media.

Apr 21, 2015

Exclusive: Top Mylan shareholders seek deal with Teva – sources

By Olivia Oran and Nadia Damouni

(Reuters) – Some of the top investors at Mylan NV (MYL.O: Quote, Profile, Research, Stock Buzz), including Paulson & Co, are encouraging its board of directors to consider a takeover proposal from rival Teva Pharmaceutical Industries Inc (TEVA.TA: Quote, Profile, Research, Stock Buzz), according to people familiar with the matter.

A handful of these investors have expressed their support for such a deal in the last few weeks, even before Teva unveiled an unsolicited $40 billion takeover proposal on Tuesday for the Canonsburg, Pennsylvania-based company, these people said, declining to be named because they were not authorized to speak to the media.

Apr 21, 2015

Exclusive: Perrigo expected to reject Mylan offer as soon as this week – source

By Nadia Damouni and Olivia Oran

(Reuters) – Perrigo Company PLC is set to reject a $29 billion unsolicited takeover offer from generics drugmaker Mylan NV as soon as this week, according to a source familiar with the matter.

A rejection leaves Mylan with no immediate alternative to a takeover offer from Teva Pharmaceutical Industries Ltd which went public on Tuesday with a $40 billion unsolicited proposal for the Canonsburg, Pennsylvania-based rival.

Apr 21, 2015

Perrigo expected to reject Mylan offer as soon as this week -source

April 21 (Reuters) – Perrigo Company PLC is set to
reject a $29 billion unsolicited takeover offer from generics
drugmaker Mylan NV as soon as this week, according to a
source familiar with the matter.

A rejection leaves Mylan with no immediate alternative to a
takeover offer from Teva Pharmaceutical Industries Ltd
which went public on Tuesday with a $40 billion unsolicited
proposal for the Canonsburg, Pennsylvania-based rival.

Apr 17, 2015

Patterson seeks sale of rehabilitation supply unit: sources

By Greg Roumeliotis and Olivia Oran

(Reuters) – Medical device supplier Patterson Companies Inc is looking to sell its rehabilitation supply business in a deal that could fetch between $500 million and $600 million, people familiar with the matter said on Friday.

Saint Paul, Minnesota-based Patterson has hired investment bank Bank of America Corp to assist with the potential sale, the people said, asking not be named because the matter is private.

Apr 15, 2015

Exclusive: Henkel, Revlon, Coty prepare bids for P&G beauty brands -sources

By Olivia Oran, Arno Schuetze and Martinne Geller

(Reuters) – Personal care and cosmetics companies Henkel & Co KGaA AG, Revlon Inc and Coty Inc are preparing bids for parts of Procter & Gamble Co’s beauty business, according to sources.

The three companies are working with investment banks ahead of a first-round bid deadline set for next week, the sources said on Wednesday. A successful sale would allow P&G to focus on more profitable consumer brands such as its Gillette razors, Tide detergent and Pampers disposable diapers.

Apr 15, 2015

Henkel, Revlon, Coty prepare bids for P&G beauty brands -sources

April 15 (Reuters) – Personal care and cosmetics companies
Henkel & Co KGaA AG, Revlon Inc and Coty Inc
are preparing bids for parts of Procter & Gamble Co’s
beauty business, according to sources.

The three companies are working with investment banks ahead
of a first-round bid deadline set for next week, the sources
said on Wednesday. A successful sale would allow P&G to focus on
more profitable consumer brands such as its Gillette razors,
Tide detergent and Pampers disposable diapers.

Apr 14, 2015

Insight – Banks see talent flee amid healthcare M&A boom

NEW YORK (Reuters) – Several high-ranking bankers have left their jobs at major investment banks in the last 13 months amid a surge in U.S. healthcare deal activity to seek better compensation at boutique investment banks as well as to participate in the growth of the industry at biotech companies themselves.

JPMorgan Chase & Co and Bank of America have both lost senior healthcare investment bankers to boutique investment bank Guggenheim Partners, showing that banks face challenges in being able to pay competitive rates. The biggest U.S. banks are under pressure from regulators to preserve more capital, rather than use M&A fees to pay higher bonuses.

Apr 14, 2015

Banks see talent flee amid healthcare M&A boom

NEW YORK, April 14 (Reuters) – Several high-ranking bankers
have left their jobs at major investment banks in the last 13
months amid a surge in U.S. healthcare deal activity to seek
better compensation at boutique investment banks as well as to
participate in the growth of the industry at biotech companies
themselves.

JPMorgan Chase & Co and Bank of America have both lost
senior healthcare investment bankers to boutique investment bank
Guggenheim Partners, showing that banks face challenges in being
able to pay competitive rates. The biggest U.S. banks are under
pressure from regulators to preserve more capital, rather than
use M&A fees to pay higher bonuses.

Apr 6, 2015

Exclusive: Data storage startup Pure Storage taps banks for IPO – sources

By Liana B. Baker and Olivia Oran

(Reuters) – Pure Storage Inc is making preparations for an initial public offering, including hiring underwriters, one year after a private placement valued the data storage company at more than $3 billion, according to people familiar with the matter.

The offering would provide a boost to what has been a slow start for U.S. technology IPOs so far this year. They were just five in the first quarter, down from 13 a year ago, according to Thomson Reuters data. This is because fast-growing companies currently prefer to raise money in the private markets at high valuations rather than go public.